Advertisement

Topics

ESA Laboratories ESAL Company Profile

00:26 EDT 22nd September 2017 | BioPortfolio

The latest in electrochemical detection platforms for HPLC from ESA This powerful new system is the next generation, modular electrochemical detector platform that is configurable for either DC, Pulse/Scan or both. It incorporates discrete, optimized electronic circuitry for each detection mode to give enhanced stability and sensitivity. The Coulochem® III provides reliable, low maintenance operation with Coulometric and amperometric detection techniques for standard to microbore HPLC.

Location

22 Alpha Road
Chelsford
MA
01824
United States of America

Contact

Phone: 1 978 250 7000
Fax: 1 978 250 7090
Email: info@esainc.com


News Articles [346 Associated News Articles listed on BioPortfolio]

Contrasting IDEXX Laboratories

IDEXX Laboratories and Heska Corporation are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, di...

Enterome to move its research laboratories

Enterome, a pioneer of innovative therapies for microbiome-related diseases announced that the Company is moving its research laboratories to Genopole, a leading biocluster dedicated to biotechnology ...

Zacks: Brokerages Anticipate Impax Laboratories Inc (IPXL) Will...

Wall Street analysts forecast that Impax Laboratories Inc will post $196.18 million in sales for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Impax Laboratories'...

Analyzing Impax Laboratories

Pfizer and Impax Laboratories are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional owner...

$0.14 EPS Expected for Impax Laboratories, Inc. (IPXL) This Quarter

Analysts expect Impax Laboratories, Inc. to report earnings per share of $0.14 for the current fiscal quarter, according to Zacks . Four analysts have provided estimates for Impax Laboratories' ea...

Zacks: Analysts Anticipate Impax Laboratories Inc (IPXL) to Announce $0.13 EPS

Equities analysts expect that Impax Laboratories Inc will post earnings per share of $0.13 for the current quarter, according to Zacks Investment Research . Four analysts have made estimates for Impax...

Morning Stock Stories: Impax Laboratories, Inc.

With a market cap of 1.21B, Impax Laboratories, Inc. has a large market cap size. Impax Laboratories, Inc. has been on the stock market since its IPO date on the 12/19/1995.

#jobs #lifescience Vector Laboratories: Marketing Manager

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Vector Laboratories: Marketing Manager . Competitive Salary and Benefits: Vec...

PubMed Articles [188 Associated PubMed Articles listed on BioPortfolio]

Project management: importance for diagnostic laboratories.

The constraints applied on diagnostic laboratories to improve both quality and productivity together with personal shortages incite laboratory managers to constantly optimize the laboratory workflows,...

Cancer incidence in female laboratory employees: extended follow-up of a Swedish cohort study.

Work in chemical laboratories is associated with exposure to chemicals, of which some are known or suspected carcinogens. A cohort study of laboratory workers in Stockholm followed until 1992 showed a...

This Is not Participatory Design - A Critical Analysis of Eight Living Laboratories.

Design of Health Technology for elderly and care personnel has a high priority because of a severe increase of elderly citizens in need of health care combined with a decrease of resources in the heal...

Consistency of BRCA1 and BRCA2 Variant Classifications Among Clinical Diagnostic Laboratories.

Genetic tests of the cancer predisposition genes BRCA1 and BRCA2 inform significant clinical decisions for both physicians and patients. Most uncovered variants are benign, and determining which few a...

CLSI-Based Validation of Manufacturer-Derived Reference Intervals on the Cobas 8000 Platform.

Reference intervals provided by diagnostic test manufacturers should be transferred to clinical laboratories after validation. Although protocols exist, laboratories rarely perform and report on resul...

Clinical Trials [231 Associated Clinical Trials listed on BioPortfolio]

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fasting c...

Companies [931 Associated Companies listed on BioPortfolio]

ESA Laboratories ESAL

The latest in electrochemical detection platforms for HPLC from ESA This powerful new system is the next generation, modular electrochemical detector platform that is configurable for either DC, Puls...

KENT LABORATORIES

Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

Rainbow Scientific, Inc.

Rainbow Scientific, Inc. markets, sells, and distributes state-of-the-art medical diagnostic test kits to both research and clinical laboratories. From our Windsor, Connecticut location, we are commit...

Bedford Laboratories

Bedford Laboratories supplies the U.S. and International markets with multisource and specialty injectable products offering a broad range of multisource injectables across multiple therapeutic classe...

Carma Laboratories Inc.

For more than 70 years, Milwaukee-based Carma Laboratories has manufactured Carmex brand lip balm. Carmex products are available at most U.S. retailers and online. For more information, contact Carma ...

More Information about "ESA Laboratories ESAL" on BioPortfolio

We have published hundreds of ESA Laboratories ESAL news stories on BioPortfolio along with dozens of ESA Laboratories ESAL Clinical Trials and PubMed Articles about ESA Laboratories ESAL for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ESA Laboratories ESAL Companies in our database. You can also find out about relevant ESA Laboratories ESAL Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record